After the end of the conflict between the pharmaceutical distribution companies and GSK, multinational pharmaceutical companies has suddenly changed their attitudes

After the end of the conflict between GlaxoSmithKline (GSK) and the pharmaceutical distribution companies, multinational pharmaceutical companies are starting to change their attitudes.

Changes in their existing policies for distribution cost that the companies had been stubborn with are starting to be sensed.

It was known that some companies already ordered their department concerned to cons...